Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: Inogen, Inc.

Market Cap 173M 149M 137M 129M 242M 16.38B 245M 1.62B 635M 8.02B 650M 636M 27.75B P/E Ratio 2026 *
-8.25x
P/E Ratio 2027 * -13.8x
Enterprise Value 173M 149M 137M 129M 242M 16.38B 245M 1.62B 635M 8.02B 650M 636M 27.75B EV / Sales 2026 *
0.47x
EV / Sales 2027 * 0.44x
Free-Float
87.36%
Yield 2026 *
-
Yield 2027 * -
1 day+0.94%
1 week+0.78%
Current month-0.46%
1 month-5.00%
3 months+6.60%
6 months-8.50%
Current year-3.87%
1 week 6.12
Extreme 6.12
6.65
1 month 5.88
Extreme 5.875
6.72
Current year 5.34
Extreme 5.3401
7.67
1 year 5.34
Extreme 5.3401
9.13
3 years 4.13
Extreme 4.13
13.33
5 years 4.13
Extreme 4.13
82.35
10 years 4.13
Extreme 4.13
287.79
Manager TitleAgeSince
Chief Executive Officer 55 2023-11-09
Director of Finance/CFO 48 2026-04-05
Chief Tech/Sci/R&D Officer - 2025-09-28
Director TitleAgeSince
Director/Board Member 66 2014-08-05
Chairman 65 2021-12-28
Director/Board Member 59 2022-03-21
Date Insider Type Main position Quantity % Market Cap.
06-04Free

Director

28,081 0.1037%
06-04Free

Director

28,081 0.1037%
06-04Free

Director

28,081 0.1037%
Change 5-day change 1-year change 3-year change Capi.($)
+0.94%+0.78%+3.36%-35.72% 173M
+0.56%-2.64%-34.62%-14.12% 154B
+0.22%-1.58%-7.90%-8.57% 103B
+0.79%+1.10%+59.84%+48.60% 55.22B
-0.09%+2.32%-4.77%+57.18% 54.8B
-0.49%-3.73%-15.50%-42.56% 40.3B
+1.97%+11.07% - - 30.96B
-1.53%+1.87%-9.48%-41.59% 29.08B
+0.79%+5.38%+49.35%-6.56% 23.23B
+1.70%-1.89%-14.26%-1.74% 20.25B
Average +0.54%+0.77%+2.89%-5.01% 51.06B
Weighted average by Cap. +0.43%-0.48%-6.52%-0.73%

Financials

2026 *2027 *
Net sales 369M 318M 293M 275M 516M 34.9B 521M 3.46B 1.35B 17.09B 1.39B 1.36B 59.14B 397M 342M 315M 295M 555M 37.5B 560M 3.72B 1.45B 18.37B 1.49B 1.46B 63.55B
Net income -21.7M -18.7M -17.21M -16.15M -30.33M -2.05B -30.64M -203M -79.49M -1B -81.43M -79.71M -3.48B -13.2M -11.38M -10.47M -9.82M -18.45M -1.25B -18.64M -124M -48.35M -611M -49.54M -48.49M -2.11B
Net Debt - -
Logo Inogen, Inc.
Inogen, Inc. is a global medical technology company offering respiratory products for use in the homecare setting. The Company partners with patients, prescribers, home medical equipment providers, and distributors to make its respiratory therapy products available. It develops, manufactures, and markets respiratory health products, including portable oxygen concentrators (POCs), used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions and the Simeox product for airway clearance treatment. It also distributes the Inogen Voxi 5 stationary oxygen concentrator as well as the Aurora continuous positive airway pressure (CPAP) masks in the United States. Its proprietary Inogen One and Inogen Rove POC systems concentrate the air around the patient to offer a source of supplemental oxygen 24 hours a day, seven days a week with a battery and can be plugged into an outlet when at home, in a car, or in a public place with outlets available.
Employees
753
Date Price Change Volume
26-06-15 6.460 $ +0.94% 172,926
26-06-12 6.400 $ +1.59% 148,374
26-06-11 6.300 $ -4.40% 308,401
26-06-10 6.590 $ +3.78% 322,094
26-06-09 6.350 $ +4.79% 529,623
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
6.400USD
Average target price
12.67USD
Spread / Average Target
+97.92%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. INGN Stock
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!